BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14597105)

  • 1. The 'immunological-synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta.
    Shapiro S; Galboiz Y; Lahat N; Kinarty A; Miller A
    J Neuroimmunol; 2003 Nov; 144(1-2):116-24. PubMed ID: 14597105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.
    Wiesemann E; Deb M; Trebst C; Hemmer B; Stangel M; Windhagen A
    Mult Scler; 2008 Mar; 14(2):166-76. PubMed ID: 17942524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone.
    Boylan MT; Crockard AD; McDonnell GV; Armstrong MA; Hawkins SA
    J Neurol Sci; 1999 Aug; 167(2):79-89. PubMed ID: 10521545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis.
    Filion LG; Matusevicius D; Graziani-Bowering GM; Kumar A; Freedman MS
    Clin Immunol; 2003 Feb; 106(2):127-38. PubMed ID: 12672403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
    Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
    Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis.
    Hussien Y; Sanna A; Söderström M; Link H; Huang YM
    J Neuroimmunol; 2001 Dec; 121(1-2):102-10. PubMed ID: 11730946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus.
    Liu MF; Li JS; Weng TH; Lei HY
    Scand J Immunol; 1999 Jan; 49(1):82-7. PubMed ID: 10023862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.
    Genç K; Dona DL; Reder AT
    J Clin Invest; 1997 Jun; 99(11):2664-71. PubMed ID: 9169496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of interferon beta-1a in multiple sclerosis.
    Liu Z; Pelfrey CM; Cotleur A; Lee JC; Rudick RA
    J Neuroimmunol; 2001 Jan; 112(1-2):153-62. PubMed ID: 11108944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell co-stimulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa.
    Rogler G; Hausmann M; Spöttl T; Vogl D; Aschenbrenner E; Andus T; Falk W; Schölmerich J; Gross V
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1105-11. PubMed ID: 10524639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CD40 ligand expressing blood T-cell levels in multiple sclerosis are reversed by interferon-beta treatment.
    Teleshova N; Bao W; Kivisäkk P; Ozenci V; Mustafa M; Link H
    Scand J Immunol; 2000 Mar; 51(3):312-20. PubMed ID: 10736102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered maturation of circulating dendritic cells in primary progressive MS patients.
    López C; Comabella M; Al-zayat H; Tintoré M; Montalban X
    J Neuroimmunol; 2006 Jun; 175(1-2):183-91. PubMed ID: 16698091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine induces CD86 expression and chemokine production by human immature dendritic cells.
    Caron G; Delneste Y; Roelandts E; Duez C; Herbault N; Magistrelli G; Bonnefoy JY; Pestel J; Jeannin P
    J Immunol; 2001 May; 166(10):6000-6. PubMed ID: 11342615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis.
    Ranheim EA; Kipps TJ
    Arthritis Rheum; 1994 Nov; 37(11):1637-46. PubMed ID: 7526869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
    Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
    Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
    Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A
    J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.